Litcius/Paper detail

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel, Axel Le Cesne, Nadia Hindi, Pablo Luna, David S. Moura, Daniel Bernabéu, Enrique de Alava, José Antonio López‐Guerrero, Joaquı́n Dopazo, María Peña-Chilet, Antonio Gutiérrez, Paola Collini, Marie Karanian, Andrés Redondo, Antonio López–Pousa, Giovanni Grignani, Juan Díaz‐Martín, David Marcilla, Antonio Fernández‐Serra, Cristina González‐Aguilera, Paolo G. Casali, Jean‐Yves Blay, Silvia Stacchiotti

2020The Lancet Oncology90 citationsDOI

Topics & Concepts

PazopanibMedicineClinical endpointInternal medicineCohortClinical trialOncologySarcomaSurgeryPathologyCancerSunitinibSoft tissue tumor case studiesIgG4-Related and Inflammatory DiseasesSarcoma Diagnosis and Treatment
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial | Litcius